Loading...
Images of Marcelo Eduardo Espinosa Bravo
(0 from 0 )News
Oxford Pharmascience “at an exciting stage” as it raises £1.1 million via placing
www.proactiveinvestors.co.uk
[Proactive Investors UK] - David Norwood, the firm's chairman, and chief technology officer Marcelo Bravo are subscribing for 10 million and 2.5 million new shares respectively. Oxford Pharmascience said that the net proceeds of the placing will be used by it to continue
sorted by relevance / date